• Brexit’s Impact on R&D Funding

    The UK is a global leader in R&D and benefits more from EU research funding than any other EU country – receiving €1bn annually. It is also home to many top researchers from other EU countries who are invaluable to maintaining the quality of UK universities. Business also benefits from such expertise and the funds…

  • UN Panel on Access to Medicines: What’s the impact on the pharmaceutical market?

    Following several months of intense discussion and negotiations, the High-Level Panel on Access to Medicines has published its report today. The 15 members of the panel, representing a wide range of experts and stakeholders in the health innovation area, have not found consensus on remedies to change the current IP system for medicines, but agreed…

Back to top